pharmaphorum| News & views on pharma and biotech’s evolving future

R&D

Sponsored

12 Questions With Trenton M. Johnson

Find out more about Senior Director of CMC Portfolio Management, Thermo Fisher Scientific, Trenton M. Johnson in a new 12 Questions With.

Digital

Frontiers Health at 10: Future health, cost, and collaborati...

Frontiers Health is all about global innovation, the future of health unfolding by grace of science across the world.

Spotlight on

Frontiers Health 2025

News

NICE backs Roche's non-Hodgkin lymphoma drug Columvi

NICE backs NHS use of Roche's Columvi as a second-line therapy for a form of non-Hodgkin lymphoma affecting thousands of people in the UK each year.

News

AbbVie exits alliance with Alphabet biotech Calico; report

Reports are emerging that a multibillion-dollar partnership between AbbVie and Calico has come to an end after more than a decade.

Featured Content

R&D

Sponsored

12 Questions With Trenton M. Johnson

Find out more about Senior Director of CMC Portfolio Management, Thermo Fisher Scientific, Trenton M. Johnson in a new 12 Questions With.

Spotlight on

Frontiers Health 2025

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Market Access

Policy in Focus: Trump’s MFN deals, FDA vouchers, and the go...

Policy experts Alice Valder Curran and Elizabeth Jungman of Hogan Lovells weigh in on Trump's MFN deals, FDA vouchers, and the government shutdown.

R&D

ESMO25: On partnerships between pharma and diagnostic develo...

Jane Li, Senior Director of Pharma CDx and CRO Partnership, Clinical Next Generation Sequencing Business, at Thermo Fisher Scientific discusses CDx.

R&D

A man stood on a rock looking towards the horizon

Sponsored

A New Framework to Engineer Breakthrough Value for Medicines

A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.

Newsletters and Deep Dive
digital magazine

Latest News

News

NICE backs Roche's non-Hodgkin lymphoma drug Columvi

NICE backs NHS use of Roche's Columvi as a second-line therapy for a form of non-Hodgkin lymphoma affecting thousands of people in the UK each year.

News

AbbVie exits alliance with Alphabet biotech Calico; report

Reports are emerging that a multibillion-dollar partnership between AbbVie and Calico has come to an end after more than a decade.

News

Novartis says novel drug could counter malaria resistance

Novartis has reported what looks like another big step forward in the treatment of malaria, as a drug with a novel mechanism hits the mark in phase 3.

News

FDA unveils swift route to market for personalised drugs

FDA reveals a regulatory pathway for personalised therapies based on 'plausible mechanism', drawing on the bespoke gene-editing treatment of Baby KJ.

Views & Analysis

Market Access

City View of London around Liverpool Street

FT Summit: How Is U.S. Policy Reshaping the UK and EU Pharma...

For the Financial Times (FT) Global Pharma & Biotech Summit in London 2025, pharmaphorum is providing coverage courtesy of NAVLIN Daily.

R&D

Sponsored

12 Questions With Trenton M. Johnson

Find out more about Senior Director of CMC Portfolio Management, Thermo Fisher Scientific, Trenton M. Johnson in a new 12 Questions With.

Digital

Frontiers Health at 10: Future health, cost, and collaborati...

Frontiers Health is all about global innovation, the future of health unfolding by grace of science across the world.

Digital

AI doesn’t have to be 100% reliable to be useful

Generative AI models aren’t perfect. They hallucinate and make mistakes. But that doesn't have to be disqualifying, say AI implementation experts.

Deep Dive

Patients

Patients and Partnerships 2025

Patients

How DTP became pharma’s newest battleground

Patients

How to land a deal with big pharma

Patients

Beyond being heard: The patient voice as a force for change

White Papers & Webinar

Sales & Marketing

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

R&D

Sponsored

A New Framework to Engineer Breakthrough Value for Medicines

A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.

Digital

Sponsored

Future proofing production: Implementing AI in pharmaceutica...

Read Zühlke’s new white paper, ‘Future Proof Production: Implementing AI in pharmaceutical manufacturing’ today.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Sponsored

Tracking studies get smarter: AI meets human intelligence

Having a continuous pulse on brand health is essential for pharmaceutical companies to inform strategic decisions and establish Key Performance Indicators (KPIs) in an ever-changing market

Podcasts & Video

R&D

ESMO25: On partnerships between pharma and diagnostic develo...

Jane Li, Senior Director of Pharma CDx and CRO Partnership, Clinical Next Generation Sequencing Business, at Thermo Fisher Scientific discusses CDx.

Market Access

Policy in Focus: Trump’s MFN deals, FDA vouchers, and the go...

Policy experts Alice Valder Curran and Elizabeth Jungman of Hogan Lovells weigh in on Trump's MFN deals, FDA vouchers, and the government shutdown.

R&D

Biotech’s biggest challenge isn’t scientific, but political ...

Oncology

Interview at ESMO 2025 with Inge Marie Svane

ESMO25: Immuno-therapies and translational research in oncol...

Dr Inge Marie Svane – Professor in Clinical cancer immune therapy and director of the translational research centre, CCIT, on IO Biotech's ESMO25 data